N N PHARMA LTD

N N PHARMA LTD

N N PHARMA LTD - Company Information

Print Friendly Version

N N PHARMA LTD

Company Registration Number:
09544387 (England and Wales)

Unaudited abridged accounts for the year ended 30 April 2019

Period of accounts

Start date: 01 May 2018

End date: 30 April 2019

N N PHARMA LTD

Contents of the Financial Statements

for the Period Ended 30 April 2019

Balance sheet
Notes

N N PHARMA LTD

Balance sheet

As at 30 April 2019


Notes
2019
2018


£
£
Fixed assets
Tangible assets: 2 990 890
Total fixed assets: 990 890
Current assets
Debtors:     5,049
Cash at bank and in hand: 77,782 62,610
Total current assets: 77,782 67,659
Creditors: amounts falling due within one year:   (37,532) (28,088)
Net current assets (liabilities): 40,250 39,571
Total assets less current liabilities: 41,240 40,461
Total net assets (liabilities): 41,240 40,461
Capital and reserves
Called up share capital: 1,000 1,000
Profit and loss account: 40,240 39,461
Shareholders funds: 41,240 40,461

The notes form part of these financial statements

N N PHARMA LTD

Balance sheet statements

For the year ending 30 April 2019 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 17 January 2020
and signed on behalf of the board by:

Name: N Nasrullah
Status: Director

The notes form part of these financial statements

N N PHARMA LTD

Notes to the Financial Statements

for the Period Ended 30 April 2019

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

N N PHARMA LTD

Notes to the Financial Statements

for the Period Ended 30 April 2019

2. Tangible Assets

Total
Cost £
At 01 May 2018 1,047
Additions 303
At 30 April 2019 1,350
Depreciation
At 01 May 2018 157
Charge for year 203
At 30 April 2019 360
Net book value
At 30 April 2019 990
At 30 April 2018 890